WKYMVM

CAS No. 187986-17-0

WKYMVM( —— )

Catalog No. M21014 CAS No. 187986-17-0

WKYMVM is a N-formyl peptide receptor (FPR1) agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 262 In Stock
10MG 391 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WKYMVM
  • Note
    Research use only, not for human use.
  • Brief Description
    WKYMVM is a N-formyl peptide receptor (FPR1) agonist.
  • Description
    WKYMVM is a N-formyl peptide receptor (FPR1) agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    FPR1?
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    187986-17-0
  • Formula Weight
    856.11
  • Molecular Formula
    C41H61N9O7S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 12.5 mg/mL (14.60 mM)
  • SMILES
    CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](CCSC)C(N)=O)C(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Christophe T Karlsson A Dugave C et al. The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2[J]. Journal of Biological Chemistry 2001 276(24):21585-21593.
molnova catalog
related products
  • UNC7467

    UNC7467 is a potent IP6K inhibitor with IC50 values of 4.9 nM for IP6K2, 8.9 nM for IP6K1, and 1320 nM for IP6K6.

  • KRAS G12C inhibitor ...

    KRAS G12C inhibitor 16 is a potent inhibitor of KRAS G12C.

  • SNAP-25 187-203

    This amino acids187 to 203 fragment is derived from the C-terminal helix of synaptosomal-associated protein of 25 kDa (SNAP-25). This peptide is able to rescue exocytosis from botulinum neurotoxin E (BoNT/E)-treated cells, albeit at higher concentrations than the full-length coil.